This company listing is no longer active
0QTA Stock Overview
A clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Guardion Health Sciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$6.27 |
| 52 Week High | US$11.90 |
| 52 Week Low | US$6.10 |
| Beta | 0.86 |
| 1 Month Change | 0% |
| 3 Month Change | 0.24% |
| 1 Year Change | -32.99% |
| 3 Year Change | -94.91% |
| 5 Year Change | n/a |
| Change since IPO | -97.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0QTA | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 0% | -2.0% | -2.6% |
| 1Y | -33.0% | -7.7% | 6.9% |
Return vs Industry: 0QTA underperformed the German Personal Products industry which returned 12.4% over the past year.
Return vs Market: 0QTA underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| 0QTA volatility | |
|---|---|
| 0QTA Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 3.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 0QTA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0QTA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 13 | Bret Scholtes | www.guardionhealth.com |
Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.
Guardion Health Sciences, Inc. Fundamentals Summary
| 0QTA fundamental statistics | |
|---|---|
| Market cap | €6.74m |
| Earnings (TTM) | -€18.83m |
| Revenue (TTM) | €10.04m |
0.7x
P/S Ratio-0.4x
P/E RatioIs 0QTA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0QTA income statement (TTM) | |
|---|---|
| Revenue | US$10.95m |
| Cost of Revenue | US$6.30m |
| Gross Profit | US$4.65m |
| Other Expenses | US$25.18m |
| Earnings | -US$20.54m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -16.67 |
| Gross Margin | 42.44% |
| Net Profit Margin | -187.54% |
| Debt/Equity Ratio | 0% |
How did 0QTA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/04/09 14:41 |
| End of Day Share Price | 2023/01/10 00:00 |
| Earnings | 2022/09/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guardion Health Sciences, Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Edward Woo | Ascendiant Capital Markets LLC |
| Anthony Vendetti | Maxim Group |